Simeprevir with interferon effective for HIV/HCV co-infected people with genotype 1 or 4 hepatitis C

Adding the direct-acting hepatitis C drug simeprevir to pegylated interferon and ribavirin produced high response rates for HIV-positive people co-infected with HCV genotype 1, researchers reported at the 14th European AIDS Conference this week in Brussels.

http://www.aidsmap.com/page/2782111/